1. Home
  2. CDXS vs EFR Comparison

CDXS vs EFR Comparison

Compare CDXS & EFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXS
  • EFR
  • Stock Information
  • Founded
  • CDXS 2002
  • EFR 2003
  • Country
  • CDXS United States
  • EFR United States
  • Employees
  • CDXS N/A
  • EFR N/A
  • Industry
  • CDXS Major Chemicals
  • EFR Trusts Except Educational Religious and Charitable
  • Sector
  • CDXS Industrials
  • EFR Finance
  • Exchange
  • CDXS Nasdaq
  • EFR Nasdaq
  • Market Cap
  • CDXS 332.0M
  • EFR 372.9M
  • IPO Year
  • CDXS 2010
  • EFR N/A
  • Fundamental
  • Price
  • CDXS $4.33
  • EFR $12.90
  • Analyst Decision
  • CDXS Buy
  • EFR
  • Analyst Count
  • CDXS 2
  • EFR 0
  • Target Price
  • CDXS $11.00
  • EFR N/A
  • AVG Volume (30 Days)
  • CDXS 684.7K
  • EFR 88.6K
  • Earning Date
  • CDXS 10-31-2024
  • EFR 01-01-0001
  • Dividend Yield
  • CDXS N/A
  • EFR 9.43%
  • EPS Growth
  • CDXS N/A
  • EFR N/A
  • EPS
  • CDXS N/A
  • EFR 1.69
  • Revenue
  • CDXS $64,446,000.00
  • EFR N/A
  • Revenue This Year
  • CDXS N/A
  • EFR N/A
  • Revenue Next Year
  • CDXS $2.02
  • EFR N/A
  • P/E Ratio
  • CDXS N/A
  • EFR $7.74
  • Revenue Growth
  • CDXS N/A
  • EFR N/A
  • 52 Week Low
  • CDXS $1.85
  • EFR $10.95
  • 52 Week High
  • CDXS $4.91
  • EFR $13.29
  • Technical
  • Relative Strength Index (RSI)
  • CDXS 69.15
  • EFR 54.42
  • Support Level
  • CDXS $3.70
  • EFR $12.80
  • Resistance Level
  • CDXS $4.20
  • EFR $13.01
  • Average True Range (ATR)
  • CDXS 0.29
  • EFR 0.09
  • MACD
  • CDXS 0.04
  • EFR 0.01
  • Stochastic Oscillator
  • CDXS 82.67
  • EFR 64.52

About CDXS Codexis Inc.

Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.

About EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest

Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of health care, industrial equipment, lodging and casinos, oil and gas, publishing, radio and television, telecommunications, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.

Share on Social Networks: